Tianxing Ye

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

The transcription factor ZNF217 drives hepatocellular carcinoma progression by activating de novo lipid synthesis via FASN upregulation.

The transcription factor ZNF217 drives hepatocellular carcinoma progression by activating de novo lipid synthesis via FASN upregulation.

Journal: Journal of cancer research and clinical oncology
Published: January 08, 2026

LncRNA LMCD1-AS1 Interacts with PHF8 to Promote Hepatocellular Carcinoma Resistance to Multikinase Inhibitors.

LncRNA LMCD1-AS1 Interacts with PHF8 to Promote Hepatocellular Carcinoma Resistance to Multikinase Inhibitors.

Journal: International journal of biological sciences
Published: December 09, 2025

Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death.

Glutamine binds HSC70 to transduce signals inhibiting IFN-β-mediated immunogenic cell death.

Journal: Developmental cell
Published: March 03, 2024

Phosphorylation determines the glucose metabolism reprogramming and tumor-promoting activity of sine oculis homeobox 1.

Phosphorylation determines the glucose metabolism reprogramming and tumor-promoting activity of sine oculis homeobox 1.

Journal: Signal transduction and targeted therapy
Published: September 24, 2023

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis.

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis.

Journal: Science advances
Published: June 09, 2023

CHMP4A stimulates CD8+ T-lymphocyte infiltration and inhibits breast tumor growth via the LSD1/IFNβ axis.

CHMP4A stimulates CD8+ T-lymphocyte infiltration and inhibits breast tumor growth via the LSD1/IFNβ axis.

Journal: Cancer science
Published: December 05, 2022

Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer.

Transcriptional Repression of Aerobic Glycolysis by OVOL2 in Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 06, 2022

RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.

RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.

Journal: International journal of biological sciences
Published: March 01, 2021

Corrigendum: MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect.

Corrigendum: MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect.

Journal: Frontiers in cell and developmental biology
Published: January 05, 2021
Showing 1-9 of 9

Last Updated: 09/26/2026